The long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination.Results from the company’s Phase 2/3 clinical trial also found that the vaccine — which uses a dosage one-tenth the level used for adults — generated a strong immune response and that it was safe.
The first two doses of the vaccine are given three weeks apart, followed by a third dose at least two months later. Dr. Isaac Bogoch, an infectious disease specialist at the University of Toronto, said that while the findings are “helpful,” more data about the vaccine in young kids are still needed.
abndpcaucus GovCanHealth jyduclos PopAlberta CMA_Docs Albertadoctors picardonhealth
80% effective at the time of vaccination, then dropping from that point in efficacy at a rate that exceeds Biden’s plummeting approval rating, as impossible as that sounds.
&& Get shot, don't get shot, who cares ? Stay out of other's business.
95% turned into 12% with the original jab. Now you expect us to believe 80% ? Giving kids heart problems for profit and the media is complicit.
Know what else is? Their natural immune systems!
Just let it go already. Everyone has moved on. And leave the kids alone, they are healthy.🙄😡
mattbc You need to be more specific. Effective against hospitalization/death, as intended? Or, is this an early observational statistic re: transmission? You're NOT going to falsely lead parents to believe that's a clinical study result for transmission protection? Are you?
Far worse than natural immunity for the young.
Be vigilant, it ain't over yet!
I argue with a friend that I will gather 1000 people on the stream, help if there are 1000 online, I will take off my bra